# A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)

> **NCT01004263** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 674 (actual)

## Conditions studied

- Acute Migraine With or Without Aura in Adolescents

## Interventions

- **DRUG:** rizatriptan benzoate

## Key facts

- **NCT ID:** NCT01004263
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-01
- **Primary completion:** 2011-04-18
- **Final completion:** 2011-04-18
- **Target enrollment:** 674 (ACTUAL)
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004263, "A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01004263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*